Top compounds associated with response to SLC16A2


Feature Type Standardized
Nominal ANOVA
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.08 0.03
mRNA PD318088 CTRPv2 pan-cancer AAC -0.081 0.04
mRNA Dasatinib GDSC1000 pan-cancer AAC 0.11 0.04
mRNA VX-11e GDSC1000 pan-cancer AAC -0.075 0.04
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.12 0.04
mRNA BI-2536 GDSC1000 pan-cancer AAC 0.12 0.04
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.1 0.04
mRNA Salubrinal GDSC1000 pan-cancer AAC 0.12 0.04
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.07 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.04
Download CSV